Childhood leukemia: electric and magnetic fields as possible risk factors. by Brain, Joseph D et al.
Whether health risks result from exposure to
power-line electric or magnetic ﬁelds (EMFs)
remains unclear. Epidemiologic studies have
repeatedly shown small associations between
measures of residential power-line magnetic
ﬁelds and childhood leukemia. The possibil-
ity that these associations are caused by bias
or confounders, however, cannot be ruled
out (Savitz 2003). In addition, extensive
investigations in animals at much higher lev-
els of EMFs have not demonstrated adverse
effects (Boorman et al. 2000). Recently, the
International Agency for Research on Cancer
(IARC 2002) designated EMFs as a class 2B
carcinogen (“possibly carcinogenic”), based
on “consistent statistical associations of high-
level residential magnetic fields with a dou-
bling of the risk of childhood leukemia.” The
California Department of Health Services
(CADHS 2002) recently issued a report con-
cluding that “EMFs can cause some degree of
increased risk of childhood leukemia, adult
brain cancer, Lou Gehrig’s disease, and mis-
carriage.” Hence, the question of whether
electric-power use has a possible role in child-
hood leukemia risk remains in the forefront
of concern.
To assess past research and suggest future
directions in the area of childhood leukemia and
EMFs, the Electric Power Research Institute
and the Harvard School of Public Health spon-
sored a workshop titled “Childhood Leukemia:
Added Risk from the Use of Electricity?”
on 8 November 2001, in Lexington, Mas-
sachusetts. This workshop brought together a
number of experts.
The epidemiologic associations reported
between EMFs and childhood leukemia
remain unexplained. Integrating all the lines of
evidence presents a challenge to accurately
evaluating potential health effects from EMFs.
Epidemiologic results, when available, often
predominate over rodent bioassay and other
laboratory data in hazard identification and
risk assessment. However, the epidemiology
studies of EMFs and childhood leukemia, all
of case–control design, pose several issues, and
the link between EMFs and leukemia has not
been supported by laboratory data. In many of
the epidemiology studies, the small proportion
of the study population classiﬁed as receiving
high exposure levels limits the precision of the
effect estimate. In addition, confounding and
differential selection and participation of con-
trols by attributes associated with exposure can
lead to biased effect estimates (Ahlbom et al.
2000; Hatch et al. 2000). Finally, the relevant
exposure metric is not known; thus, it has not
been possible for epidemiologists to quantify
EMF exposure appropriately in the study pop-
ulations. Experimental approaches also have
limitations, such as a) requiring high-dose to
low-dose extrapolation, b) requiring inter-
species extrapolation, c) using “pure” EMF sig-
nals of specific frequency and field strength
that may not mimic real human exposures,
and d) being subject to practical and logistic
bounds on study size (statistical power).
Epidemiologists have been hampered because
experimental studies of EMFs have not identi-
ﬁed biologic mechanism(s) that could serve as
the basis for designing new studies. The goal of
the workshop described here was to review the
science and consider new directions for EMF
research in the areas of epidemiology, exposure
metrics, animal studies, and biophysics.
Childhood Leukemia and EMFs
A major focus of EMF research during the past
20 years has been to determine whether, and
how, EMFs might increase the risk of cancer,
particularly childhood leukemia. The rationale
for investigating EMFs stems from the original
observation that childhood leukemia correlated
with the proximity of overhead utility lines
(Wertheimer and Leeper 1979). Early research
focused on quantifying EMF exposure by elec-
trical wiring conﬁgurations (“wire codes”) and
determining whether wire codes were accurate
surrogates for magnetic-ﬁeld exposure. More
recently, however, magnetic-field exposure
itself (“spot” and 24-hr average) has become
the focus of investigation (Ahlbom et al. 2001;
Greenland et al. 2000).
If typical residential magnetic fields are
used as the exposure metric, then adverse
EMF effects are not expected to occur. In a
review of the EMF literature, the National
Institute of Environmental Health Sciences
(NIEHS 1999) identiﬁed 1 mV/m as a tissue
electric ﬁeld that could plausibly be associated
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Numerous epidemiologic studies have reported associations between measures of power-line electric
or magnetic ﬁelds (EMFs) and childhood leukemia. The basis for such associations remains unex-
plained. In children, acute lymphoblastic leukemia represents approximately three-quarters of all
U.S. leukemia types. Some risk factors for childhood leukemia have been established, and others are
suspected. Pathogenesis, as investigated in animal models, is consistent with the multistep model of
acute leukemia development. Studies of carcinogenicity in animals, however, are overwhelmingly
negative and do not support the hypothesis that EMF exposure is a significant risk factor for
hematopoietic neoplasia. We may fail to observe effects from EMFs because, from a mechanistic per-
spective, the effects of EMFs on biology are very weak. Cells and organs function despite many
sources of chemical “noise” (e.g., stochastic, temperature, concentration, mechanical, and electrical
noise), which exceed the induced EMF “signal” by a large factor. However, the inability to detect
EMF effects in bioassay systems may be caused by the choice made for “EMF exposure.” “Contact
currents” or “contact voltages” have been proposed as a novel exposure metric, because their magni-
tude is related to measured power-line magnetic fields. A contact current occurs when a person
touches two conductive surfaces at different voltages. Modeled analyses support contact currents as a
plausible metric because of correlations with residential magnetic ﬁelds and opportunity for expo-
sure. The possible role of contact currents as an explanatory variable in the reported associations
between EMFs and childhood leukemia will need to be clariﬁed by further measurements, biophysi-
cal analyses, bioassay studies, and epidemiology. Key words: childhood leukemia, contact currents,
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with a biologic effect. At 5 µT (equivalent to
50 mG), which is roughly five times higher
than the highest average ﬁeld recorded in the
“1,000-home study” (Zaffanella 1993), the
induced-electric-field level in human tissues,
including bone marrow, remains below this 1
mV/m “benchmark” dose (Kavet et al. 2001).
Nonetheless, when Greenland et al. (2000)
pooled the epidemiology studies of childhood
leukemia, they found evidence of increased
risk at the upper-end magnetic ﬁeld levels to
which a small proportion of U.S. residents are
exposed. The authors estimated a relative risk
(RR) of 1.7 [95% confidence interval (CI),
1.2–2.3] for exposures above 0.3 µT (3 mG),
and a population attributable fraction of 3%
(95% CI, –2% to > 8%) for exposures above
0.05 µT. Another pooled analysis by Ahlbom
et al. (2000) produced similar results for a
0.4-µT cut point. The data from the 1,000-
home study (Zaffanella 1993) show that 4.7%
of residences in the United States have average
spot measurements (point-in-time measure-
ments averaged across available rooms)
≥ 0.3 µT, and 2.6% have ﬁelds ≥ 0.4 µT.
Interpretation of the associations between
childhood leukemia and EMFs rests on under-
standing several lines of evidence: a) clinical
data on etiology and pathogenesis of childhood
leukemia; b) results from EMF-exposed labora-
tory animals; c) survey data on EMF levels pre-
sent in households and whether the intensity is
sufﬁcient to induce biologic effects; and d) con-
sideration of alternative EMF exposure metrics.
Biology of Childhood Leukemia
Leukemia is a cancer of blood progenitor cells
that arises in the bone marrow, where stem cells
normally differentiate into lymphoid and
myeloid progenitor cells. Lymphoid progenitor
cells form mature B cells or T cells. Myeloid
progenitor cells yield neutrophils, monocytes, or
eosinophils. Marrow precursor cells also produce
red blood cells and platelets. Leukemia can be
classiﬁed according to the presumed cell of ori-
gin (myeloid or lymphoid) as well as its clinical
course (chronic or acute). Chronic lymphocytic
leukemia and chronic myelogenous leukemia,
which likely originate in primitive stem cells, are
characterized by protracted, subacute disease.
Acute lymphoblastic leukemia (ALL) and acute
myelogenous leukemia (AML) refer to cancer of
lymphoid or myeloid progenitor cells, with
rapid onset and deterioration without aggressive
therapy. Most childhood leukemia is either ALL
or AML. Leukemia can be further subclassiﬁed
according to morphology, genetic alterations,
cell surface markers, and other characteristics
(Table 1).
Childhood leukemogenesis is likely a multi-
step process. For ALL, speciﬁc oncogene-associ-
ated translocations and other abnormalities
have been identiﬁed in 45% of cases, and ran-
dom translocations in an additional 25%; but
in 30% of the children with ALL, specific
genetic alterations have not been identified
(Look 1997). Factors predisposing to the devel-
opment of leukemia in children include under-
lying genetic disorders, family history, ionizing
radiation, chemotherapeutic agents, and possi-
bly infection or environmental chemicals. The
underlying genetic disorders associated with an
increased risk of developing childhood leu-
kemia include Down syndrome (overall 15-
fold increase in risk), defects in DNA repair
(Bloom syndrome, Fanconi anemia), congen-
ital marrow failure (Kostmann syndrome,
Diamond-Blackfan anemia, and Schwachman-
Diamond syndrome), neuroﬁbromatosis type
I, and Li-Fraumeni syndrome (Miller 1967;
Robison and Neglia 1987).
Family history is a risk factor for the
development of childhood leukemia. In iden-
tical twins, there is a 25% concordance rate,
which is highest in infancy. However, if the
diagnosis is made in one sibling after 7 years
of age, leukemia risk does not appear to be
increased in the other sibling (Miller 1967).
Few environmental or exogenous agents
are known to cause the development of child-
hood leukemia. Postnatal ionizing radiation is
a contributing factor. Survivors living within
1,000 meters of the atomic bomb blast in
Japan showed a 20-fold increase in leukemia
rates; however, children exposed to these
bombs in utero did not exhibit an increased
risk of leukemia (Miller 1967). Pediatric
patients given therapeutic irradiation exhibit
higher leukemia rates. Similarly, after certain
kinds of chemotherapy, there is an increased
risk of developing AML (Pui et al. 1989;
Tucker et al. 1987).
In contrast to these few known agents, the
number of suspected risk factors is much
greater. Sources of radiation from prenatal
exposure, nearby nuclear plants, or natural
background have all been considered as risk
factors, as well as radon from groundwater or
indoor sources. Investigation into causal factors
has included chemical exposures from maternal
or child medications, pesticides, parental
smoking, or parental occupation. Factors asso-
ciated with pregnancy and early development,
such as maternal pregnancy history, maternal
age, birth weight, birth order, and breast-feed-
ing, have also been considered as potential risk
factors. A role for infections in childhood
leukemogenesis has been proposed from two
perspectives. Greaves and colleagues (Greaves
1997; Greaves and Alexander 1993) suggest
that unusual timing of postnatal infections
could provoke recruitment and proliferation
of undifferentiated B cells or T cells with
preleukemic translocations. Kinlen (1995,
1997) has proposed that common infections
can occasionally trigger a leukemic response,
and that an increased leukemia risk is evident
when comparing leukemia rates of populations
with unusually large inﬂuxes of new residents,
Table 1. Childhood leukemia types, subtypes, and features.
Type (%) Subtype (%) Morphology Common genetic abnormalities (%) Characteristics
ALL (74) B progenitor (80–85) L1, L2 t(12;21) (20) Precursor B-cell markers on cell surface,
t(9;22) (4) no surface immunoglobulin,
11q23 translocations (6) ploidy abnormal in 35% of cells
t(1;19) (5)
T cell (10–15) 7q35/TCRβ (3) T-cell markers on cell surface,
14q11/TCRαg (4) higher median age of patients,
9p deletions higher white blood cell count,
bulky disease, male predominance
Mature B cell (1–2) L3 t(8;14), t(2;8), or t(8;22) (2) Surface immunoglobulin, same as
Burkitt’s lymphoma
AML (19) Undifferentiated (2) MO Monosomy 5/7
Myeloblastic (45) M1, M2 t(8;21)
Promyelocytic (10) M3 t(15;17) DIC (bleeding)
Myelomonocytic (20) M4 11q23/MILL Infants, chloromas, secondary AML
Myelomonocytic with eosinophiliaa M4Eo Inversion 16
Monocytic (17) M5 11q23 translocations Infants, chloromas, secondary AML
Erythroleukemia (1) M6 Exceedingly rare in children
Megakaryocytic (5) M7 t(1;22) Down syndrome, infants, myeloﬁbrosis
DIC, disseminated intravascular coagulation.
aPercent not available.
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among stable populations.
Epidemiology of Childhood
Leukemia
Although cancer in childhood (younger than
20 years) is rare, childhood leukemia is the
most common form of childhood cancer and
represents about one-third of the total child-
hood cancers in the United States (Linet et al.
1999). For children 0–20 years old, leukemia
rates average around 2–3 per 100,000 person-
years, but the rate peaks at two or three times
this level in 0–4-year-olds. ALL constitutes
about three-fourths of U.S. cases of childhood
leukemia. Each year, about 2,400 new cases of
childhood ALL are reported, with an inci-
dence of approximately 3 per 100,000. Age-
specific incidence rates are slightly higher in
whites than in blacks at most ages, but
between 3–4 years of age, white children show
a dramatic peak in rates not seen in black chil-
dren. Male:female ratios show slightly higher
risk for males (1.2:1.0 for all ages), except
between 15 and 19 years of age, when the
male:female ratio is 2:1. AML constitutes
about one-fifth of U.S. cases of childhood
leukemia. In contrast to ALL, AML rates do
not show a peak at younger ages, and marked
gender differences are not apparent at any age.
Childhood leukemia rates vary by geo-
graphic locale and ethnicity. In general, ALL
rates are the highest in the United States
(whites only) and Europe, intermediate in India
and China, and the lowest in North Africa and
the Middle East. Great Britain reports similar
rates and patterns as the United States (Draper
1991). Internationally, however, ALL leukemia
rates exhibit a 4-fold range, from about 2 cases
per 100,00 person-years in Bangalore, India, to
about 8 cases per 100,000 person-years in
Costa Rica, in 0–4-year-olds (Parkin et al.
1998). In Africa, T-cell and mature B-cell
leukemias are more frequent than is the B-cell
progenitor subtype, which may be due to the
high incidence of Burkitt’s lymphoma associ-
ated with AIDS. For AML, the higher inci-
dences are reported in Asia, with lower rates in
North America and India.
In the United States, childhood leukemia
incidence rates differ by race within geographic
areas, but they are similar for the same race
among different geographic areas (NCI 2003).
In general, leukemia rates are the highest for
white children from higher social classes. For
black children, the 0–4-year-old ALL case rates
per 100,000 person-years are 2.4 (Greater
Delaware Valley), 2.5 (Los Angeles), 2.8
[SEER (Surveillance, Epidemiology and End
Results) areas], and 2.9 (New York State); for
white children, the rates are 5.9 (Greater
Delaware Valley), 6.9 (Los Angeles), 6.2
(SEER areas), and 6.2 (New York State) for
the same age group.
In the United States, the overall incidence
for childhood leukemia has been declining over
the past several decades (NCI 2003). Data
from 1973 through 1994 show 10.5–13.3%
decreases in leukemia incidence, depending on
age group. Advances in treatment have led to
even more dramatic declines in leukemia mor-
tality, with corresponding increases in 5-year
survival rates.
Some have suggested that investigations of
childhood leukemia “clusters” might provide
clues to the association between childhood
leukemia and environmental agents, such as
EMFs. Apparent clustering may arise for etio-
logic, statistical, or sociologic reasons. One
U.S. childhood leukemia cluster was reported
in Woburn, Massachusetts. Local residents
from the east side of Woburn identified a
transient, approximate doubling, of the child-
hood leukemia incidence rate. This area had
been highly industrialized since the 1700s,
and polluted well water was detected in the
1970s. In an extensive follow-up analysis, the
Massachusetts Department of Public Health
(1997) confirmed 19 cases of childhood
leukemia but found little or no association
with children drinking the polluted water
(RR = 1.2; 95% CI, 0.3–5.0). An exceedingly
imprecise result was reported for pregnant
mothers drinking the polluted water, with a
95% CI covering a 100-fold range (RR = 8.3;
95% CI, 0.7–94.7). The extreme imprecision
is attributed to the small sample size, which is
a problem in most cluster investigations. For
comparison, in EMF studies (Greenland et al.
2000) even the smallest leukemia case group
was twice as large as the case group in the
Woburn study. Although clusters are often
the focus of media attention, the examination
of cluster studies has not been particularly
informative in elucidating additional factors
in the development of childhood leukemia or
other diseases (Gawande 1999).
Pathogenesis of Acute
Leukemia
The multistage process in the development of
acute leukemias includes an initial event, a
survival or proliferation advantage that causes
clonal expansion, additional genetic or epi-
genetic events that promote escape from
programmed cell death or block cell differen-
tiation, and finally, functional bone marrow
failure with clinical disease. As discussed
above, some of the initiating events are chro-
mosomal translocations. For example, treat-
ment of patients having solid tumors with
inhibitors of topoisomerase II, such as etopo-
side, can induce translocations involving the
Mll gene on chromosome 11q23, leading to
AML or ALL.
In cases where genetic alterations con-
stitute a critical component of the disease
process, use of transgenic mice can provide
valuable information on pathogenesis. The
mutations induced by chromosomal transloca-
tions in human leukemias can be introduced
into laboratory mice, and leukemogenicity can
be assessed in distinct target cells. In one
model, altered DNA is introduced in vitro to a
fertilized mouse egg. The genetically altered
egg is implanted into a foster mother. One of
her progeny will then carry the altered genes
and can be bred to generate additional mice
for experimental studies. A major disadvantage
of this system is that the transgene is present
in all tissues, not just the bone marrow.
Alternatively, bone marrow can be harvested
from donor mice, altered genetic material
introduced in vitro, and the transduced bone
marrow transplanted into irradiated syngeneic
(genetically identical) recipient mice. However,
this model system is labor intensive, and exper-
imental variability does occur.
Using these model systems, several
aspects of acute leukemia pathogenesis have
been elucidated:
•T ranslocation-induced leukemia oncogenes
often confer disease speciﬁcity (see Table 1).
• Leukemia-speciﬁc oncogenes are insufﬁcient
as single agents to induce an acute leukemia
phenotype in mice (Higuchi et al. 2002).
• In contrast to acute leukemias, chronic myel-
ogenous leukemia is likely the consequence
of a single genetic event (Philadelphia chro-
mosome translocation) (Li et al. 1999).
• Cellular context determines the response of
the hematopoietic system to leukemia onco-
genes (Li et al. 1999).
• Continued expression of some leukemia
translocation oncogenes is required for
maintenance of the leukemia phenotype
(Huettner et al. 2000).
• Disruption of the ARF/p53 tumor suppres-
sor pathway is a major step in the progres-
sion of acute leukemia (Eischen et al. 1999;
Unnikrishnan et al. 1999).
Further studies of EMF effects on hemato-
poietic cell lines should be based on B-lym-
phoid development and could be useful for
identifying pathways that might be comple-
mented in a mouse model. Mouse models,
however, may be insensitive to weak EMF
effects. For example, in p53 knockout mice,
inactivation of both alleles for p53 greatly
increases the percentage of lymphomas and
decreases the survival time of affected animals,
but residential EMF exposure may not be
strong enough to inactivate the second allele
(Jacks et al. 1994).
Animal Carcinogenicity
Studies with EMFs
Epidemiologic studies are often inconclusive
and may report associations in the absence of a
causative link. In such situations, well-designed
and controlled studies using experimental
model systems can provide critical data for
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have been used to evaluate the cancer risk from
exposure to 60-Hz magnetic ﬁelds: a) chronic
oncogenicity bioassays, b) oncogenicity bioas-
says in genetically engineered (transgenic or
knockout) mice, and c) multistage (co-carcino-
genesis or tumor promotion) studies.
Chronic oncogenicity evaluations. The
advantages of chronic oncogenicity bioassays
include their use of standardized models and
study designs that are widely accepted by regu-
latory agencies. Two-year oncogenicity studies
in rodents are supported by a large historical
database assembled for numerous chemical
and physical agents. These assessments have
demonstrated value for predicting human
responses. Disadvantages of the animal studies
include the need for interspecies extrapolations
of organ-specific effects and the common
requirement to extrapolate data from high-
dose experimental exposures to low-dose
human exposures.
Three large-scale, long-term studies of EMF
exposure have been conducted in rats (Boorman
et al. 1999; Mandeville et al. 1997; Yasui et al.
1997) and two in mice (Babbitt et al. 2000;
McCormick et al. 1999). Descriptions and
ﬁndings from these investigations are summa-
rized in Table 2. Using identical study designs
and exposure protocols, McCormick, Boorman,
and co-workers examined the tumorigenic effect
of EMFs in rats and in mice. The authors evalu-
ated hematopoietic neoplasias and other puta-
tive target tissues (breast, brain) for solid
tumors. Male rats exposed intermittently to
1,000 µT (10 G) exhibited a statistically sig-
nificant decrease in leukemia incidence; no
signiﬁcant effects occurred in female rats or in
other groups of males. In female mice exposed
intermittently to 1,000 µT, a statistically sig-
niﬁcant decrease in malignant lymphoma was
observed; no effects occurred in male mice or
in other groups of females. For both rats and
mice, the authors reported no signiﬁcant dif-
ferences in the incidence of breast or brain
tumors in any group. Using different exposure
protocols, Yasui et al. (1997) reported no dif-
ferences in leukemia or lymphoma incidences
in rats exposed to either 500 µT or 5,000 µT
(5 or 50 G). Likewise, Mandeville et al. (1997)
reported no effects on the incidence of leu-
kemia in female rats exposed to 2, 20, 200, or
2,000 µT (0.02, 0.2, 2, or 20 G). Finally,
Babbitt et al. (2000) saw no differences in
total hematopoietic neoplasms or lymphomas
in female mice exposed to 1,400 µT (14 G)
(circularly polarized) EMFs.
Evaluations in genetically altered mice.
The advantages of using transgenic mice are
that weak effects can be magniﬁed and effects
occurring only in sensitive subpopulations can
be detected. Relevant mechanisms of action
may also be identiﬁed in sensitive animal mod-
els. However, if the historical database is small
or nonexistent, there is limited context with
which to interpret the data. Also, for many of
these sensitive-animal models, their ability to
predict human responses is unknown.
Two models have been developed in trans-
genic mice and applied to the investigation of
EMF effects. In the first model, Berns et al.
(1994) developed a transgenic mouse carrying
the pim-1 oncogene. After a single dose of
N-ethyl-N-nitrosourea, lymphoma develops
within 4–6 months; neoplastic cells show T-cell
markers. If no carcinogen is given, spontaneous
T-cell and B-cell lymphomas develop within
15–18 months. Animals die shortly after lym-
phoma is apparent, and therefore, survival is a
useful indicator of disease progress. This model
has been used in two studies investigating the
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Table 2. Oncogenicity studies in animals exposed to EMF over a lifetime.
Species Group size Exposure Percent incidence of hematopoietic neoplasia Reference
Rats (F344) 100/both sexes/ Leukemia: male Leukemia: female Boorman et al. (1999)
exposure group Sham control 50 20
10 G (continuous) 50 25
10 G (intermittent; 1 hr on/off) 36* 22
2 G (continuous) 47 24
0.02 G (continuous) 44 18
60 Hz, 18.5 hr/day
Rats (F344) 48/both sexes/ Leukemia: male Leukemia: female Yasui et al. (1997)
exposure group Sham control 10 16
50 G 8 14
5 G 8 12
Lymphoma: male Lymphoma: female
Sham control 0 0
50 G 0 2
5 G 0 2
50 Hz, 22.6 hr/day
Rats (F344) 50 female/ Leukemia Mandeville et al. (1997)
exposure group Sham control 10
20 G 10
2 G 6
0.2 G 18
0.02 G 8
60 Hz, 20 hr/day
Mice 100/both sexes/ Lymphoma: male Lymphoma: female McCormick et al. (1999)
(B6C3F1) exposure group Sham control 8 32
10 G (continuous) 7 26
10 G (intermittent) 6 20*
2 G (continuous) 4 22
0.02 G (continuous) 7 31
60 Hz, 18.5 hr/day
Mice 190 or 380 female/ Total hematopoietic neoplasms Babbitt et al. (2000)
(C57BL/6) exposure group Sham control 56
14 G (circularly polarized) 59
Lymphoma
Sham control 35
14 G (circularly polarized) 37
60 Hz, 18 hrs/day
*p < 0.05 versus sham control.
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McCormick et al. 1998). Survival and lym-
phoma incidence were unaffected in several dif-
ferent EMF exposure formats (Table 3). In the
second model (Donehower 1996), one (hem-
izygous) or both copies of the p53 gene are
deleted from the germ line. McCormick et al.
(1998) evaluated lymphoma incidence in TSG-
p53 mice exposed to 1,000 µT (10 G) continu-
ous EMFs (Table 3). EMF exposure had no
effect on survival and lymphoma incidence.
Multistage (promotion) studies. Multistage
study designs have the potential to identify
weak effects and thus have increased sensitivity.
They are useful for identifying nongenotoxic
effects or effects that occur only in populations
exposed to other agents. Their primary disad-
vantage relates to their unknown accuracy for
predicting human responses.
Two promotional studies have investigated
the response of mice to EMFs in conjunction
with ionizing radiation (Babbitt et al. 2000) or
dimethylbenz[a]anthracene (Shen et al. 1997).
The study design and ﬁndings are summarized
in Table 4. No increases in lymphoma inci-
dence due to the EMF exposure occurred in
these two studies.
EMFs and Interactions with
Matter
If power-line EMFs initiate or modulate the
onset of disease in humans, then it should be
possible to identify a mechanism by which
EMFs alter molecules, chemical reactions, cell
membranes, or biologic structures in a func-
tionally signiﬁcant manner. An “electric ﬁeld”
is produced by electrically charged objects,
such that the size and direction of the electric
field predicts the size and direction of force
on electric charges. Likewise, a “magnetic
ﬁeld” is produced by moving charges, and the
magnetic field predicts force on moving
charges. Therefore, any EMF bioeffects must
solely and ultimately be the result of forces;
there are no other actions of EMFs. The plau-
sibility of a biologic effect depends on
whether EMF forces can signiﬁcantly modify
biologic processes having electrically respon-
sive elements [e.g., ions, charged proteins,
neural electric currents, magnetic molecules
(free radicals), and magnetic particles].
The measurement units used for EMFs
reﬂect the force exerted. The unit of measure
for electric fields is volts per meter (V/m),
which is identical to newtons per coulomb
(N/C), where the newton is the metric unit
for force, and the coulomb is the metric unit
for quantity of electric charge; that is, the elec-
tric ﬁeld gives the force per unit charge. The
unit of measure for magnetic ﬁeld is the tesla
(T); typical environmental fields are in the
microtesla (µT) range, which is one-millionth
of a tesla. A metric unit, the tesla is identical
to newtons/ampere-meter (N/A-m), and
therefore, the magnetic field gives force per
unit length (meter) of unit current (ampere).
Next, one can ask how the forces and
energies conveyed by EMF exposure compare
with forces and energies endogenous to bio-
logic systems. As discussed below, the energies
and forces exerted by environmental, 60-Hz
EMFs seem well below those present in bio-
logic systems. That is, normal living cells oper-
ate under conditions of energy and force
“noise” such that 60-Hz EMF effects will be
lost in this background. Theoretically, one
could postulate that a low-noise, multicellular
organ system might respond to feeble EMF
inﬂuences and separate them from noise, similar
to what happens in a manmade electronic cir-
cuit that responds to 60-Hz EMFs. However,
the construction of a biologic system capable of
responding to 60-Hz EMFs imposes severe size,
averaging time, temperature stability, and con-
ductivity constraints. Although sharks can
respond to extremely weak, slowly changing
electric fields in seawater, their sensor organ
(ampulla of Lorenzini) is complex, containing a
large number (~10,000) of receptor cells, in
which small interactions are integrated to gener-
ate a change that stands out against noise (Adair
2001; Adair et al. 1998). Aside from such spe-
cialized sensory systems, fundamental force
and energy considerations appear to preclude
disruption of biology by weak EMFs. Table 5
lists mechanisms by which EMFs might alter
biologic function, but the strengths of EMF
interaction energies and forces are found to be
small compared with the endogenous energies
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Table 3. EMF studies in genetically engineered mice.
Species Group size Exposure Percent incidence of lymphoma Reference
Mice 30/both sexes/ Male Female McCormick et al. (1998)
(pim-1) exposure group Sham control 49 47
10 G (continuous) 23* 47
10 G (intermittent) 57 53
2 G (continuous) 43 45
0.02 G (continuous) 47 45
60 Hz, 18.5 hr/day, for 26 weeks
Mice 100 female/ T-cell B-cell Harris et al. (1998)
(pim-1) exposure group Sham control 5 23
10 G (continuous) 8 22
10 G (intermittent) 7 28
1 G (continuous) 8 18
0.01 G (continuous) 4 25
50 Hz, 20 hr/day, up to 18 months
Mice 30/both sexes/ Male Female McCormick et al. (1998)
(TSG-p53) exposure group Sham control 3 3
10 G (continuous) 0 7
60 Hz, 18.5 hr/day, for 26 weeks
*p < 0.05 versus sham control.
Table 4. Multistage oncogenicity studies with EMF.
Species Group size Exposure Percent incidence of lymphoma Reference
Mice 380 female/ X-ray: 3.0 Gy 4.0 Gy 5.1 Gy Babbitt et al. (2000)
(C57BL/6) exposure group Sham control 41 38 53
14 G 34 41 47
(circular) 60 Hz, 18 hr/day, lifetime
Mice 155–165/ Dimethylbenz[a]anthracene: Shen et al. (1997)
(Swiss Webster) exposure group Sham control 24
10 G 22
50 Hz, 3 hr/day, 5 days/week, for 16 weeks
Children’s Health | Brain et al.and forces characteristic of the living system
(Valberg et al. 1997).
Table 5 shows that, in terms of energy or
force at the whole-body scale or at the molecu-
lar scale, the effect of “large” EMFs is many
orders of magnitude below the typical forces
and energies that accompany life processes. For
example, x-rays can produce significant mo-
lecular damage even when the total energy
deposited in the body is small. However, the
energy of a 60-Hz EMF photon is vastly less
than that of x-rays and is too weak to alter
molecular structures. The intensity of the elec-
tric field per se could be increased to levels
where it accelerates individual free electrons to
electron-volt energies, exceeding those needed
to break a chemical bond (e.g., in corona dis-
charge). However, the level of electric-field
intensity required for this type of molecular
damage is far above what a person is exposed to
in environmental, power-line EMFs.
Likewise, EMF forces on biologic structures
can be calculated easily, but the force required
to distort the shape of complex biologic mole-
cules—for example, DNA or enzymes—is far
larger than what the electric component of
EMFs can provide. However, the magnetic
component of EMFs will act on magnetic parti-
cles or with single-molecule magnetic dipole
(e.g., free radicals). Although magnetite parti-
cles are plausible geomagnetic field sensors
(Kirschvink et al. 1992, 2001), functional bio-
genic ferromagnetic material has been estab-
lished only in a limited number of organisms
(e.g., magnetotactic bacteria). In these organ-
isms, the magnetic interaction provides sensory
guidance and is not likely to lead to internal
malfunctions. Although magnetic forces may be
adequate to twist ferromagnetic particles, the
response of the particles to EMFs is limited by
the reversal of the power-line magnetic field
direction 120 times every second. That is, the
net twist over any 1/60th of a second will be
zero, and because of the viscosity of biologic
materials, only a tiny amount of twist will take
place during the 1/120th of a second that the
magnetic ﬁeld points in a given direction.
Coupling of EMFs to biologic effects. Most
theoretical analyses of EMF actions have
emphasized physical parameters and have ana-
lyzed models of individual cells or subsystems
of single cells (mainly membranes and magne-
tosomes) (Adair 1991, 1994; Kirschvink et al.
2001; Polk 1992, 1994; Weaver and Astumian
1990). The shark provides an example of how a
multicellular system can detect weak electric
ﬁelds (described above), and the possibility that
some multicellular structures may amplify e-
lectric fields has been considered (Fear and
Stuchly 1998; Gowrishankar and Weaver
2003). The importance of biologic system size
also has been emphasized in a model for the
biologic detection of small magnetic ﬁeld differ-
ences (Weaver et al. 2000). Multicellular system
models begin with the recognition that EMFs
are physical, not chemical, agents, as illustrated
in the following causal chain (Weaver 2002):
EMFs → Physics → Chemistry → Biology
A necessary condition for biologic activity
is that EMF-induced changes must exceed
chemical changes from natural or background
inﬂuences. Changes in biology are coupled to
EMFs through changes in biochemistry, which
in turn must have an ongoing, metabolically
driven chemical process (reaction or transport
rate) that is sensitive to EMFs. The assumption
behind predicting the “weakest” detectable
ﬁeld is that this limit is determined by the abil-
ity of weak ﬁelds to alter the biochemistry, but
it is not limited by the ability of a small num-
ber of molecules to alter the biologic system.
A key consideration is the size of the
EMF-induced chemical change relative to
naturally occurring changes in the same
chemical process, which can be thought of as
a chemistry-based signal-to-noise (S/N) ratio.
For example, the signal (S) can be the EMF-
induced, accumulated change in an ionic or
molecular ﬂux (Astumian et al. 1995), or the
change in the average number of receptor-
bound ligands (Weaver et al. 2000). But the
accumulated change in flux or receptor-
bound number also varies because of other
natural processes, which constitute a general-
ized chemical noise (N), including the sources
listed in Table 6. The totality of the sources
of competing chemical change on Table 6,
(N∆N + N∆T + N∆C + N∆M + N∆E), can be
expected to be much larger for humans
in vivo than for cellular preparations studied
in vitro (Weaver et al. 1999). Therefore, for
the intact organism, the overall chemistry-
based signal-to-noise ratio can be written
symbolically as
The question of how to add the various com-
peting chemical changes has not been fully
addressed. If the competing changes can be
regarded as random (and independent), then
each of the competing changes can be added
as the sum of their magnitudes squared
(Weaver et al. 1999). In summary, the in vivo
human biochemical environment exhibits
considerable noise. This inherent, background
noise must be quantitatively reconciled with
the relatively small levels of 60-Hz EMF “sig-
nal” if one is to predict alteration of ongoing
biochemical processes by EMFs. The effect
threshold for voltage-gated channels in single,
long cells is predicted to be about 50 V/m,
which in a human-sized organism corresponds
to the electric ﬁeld induced by a magnetic ﬁeld
of about 1 T (10,000 G) (Weaver et al. 1999).
If temperature noise is ignored, the threshold
electric field is about 0.1 V/m, which corre-
sponds to a magnetic ﬁeld of 6,000 µT (60 G)
(Weaver et al. 1999). As system size increases,
fundamental noise tends to increase at a
slower rate than does the induced EMF signal.
Hence, the constraint that signal should
exceed noise (S/N > 1) is more likely to be met
in a large, multicellular system rather than in
individual, isolated cells (Weaver et al. 2000).
Another difficulty in coupling EMFs to
biologic effects has been assessing perturba-
tions in membrane transport systems. An
improved approach for evaluating molecular
transport has been developed that might have
application to predicting EMF effects on cell
function (Gowrishankar and Weaver 2003),
which uses a multicellular model based on
elementary transport models that can be
assembled into both membranes and bulk
electrolyte. The model can predict voltages,
currents, dissipated power density, and chem-
ical changes throughout the system.
Simulation of the bone marrow by the lattice
transport model may be particularly appropri-
ate in testing the hypothesis that contact cur-
rents are a potential causal link between
EMFs and childhood leukemia. Marrow
within bone is mechanically protected from    
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Table 5. Biologic process strength compared with EMF interaction strength.
Interaction strength
Interaction process in living system Interaction strength for typical “large” EMF levelsa
Heating Basal metabolism Absorbed 60-Hz EMF energy = ~0.00001 W
~100 W (i.e., 10 µW is 10,000,000-fold below basal metabolism)
Photon absorption Chemical bond 60-Hz EMF photons = ~0.000001 eV
energies of (i.e., EMF ~1 µeV, vs. x-rays ~500–5,000 eV)
~0.1–5 eV
Force (electrical) Biologic forces Molecule with electric charge of ±100 = ~0.0002 pN
~1–100 pN (pN = 10–12 N = 0.000000000001 N)
Force (magnetic) Biologic forces Twisting force on microscopic ferromagnetic particles
~1–100 pN (acting like compass needles), ~2 pN, but EMF force
alternates direction every 1/120th sec, and averages to zero
Biochemistry Free-radical Free-radical chemistry requires larger ﬁelds, and any
recombination effects occur over nanoseconds, so 60-Hz
lifetimes ~2 nsec ﬁeld with period of 17 msec appears same as static ﬁeld
ae.g., E = 1,000 V/m and M = 100 µT (or 1,000 mG).
Children’s Health | Leukemia and electric and magnetic fieldsmotion [a source of generalized noise, (N∆M)
(Vaughan and Weaver 1998)], and should
also partially attenuate biologically generated
electric fields, potentially decreasing back-
ground ﬁeld noise, (N∆E).
Contact Currents as a Possible
Explanatory Exposure
A “contact current” occurs at home or in the
workplace when a person touches two conduc-
tive surfaces that are at different electrical volt-
ages. Typically, these currents may ﬂow from
hand to hand or from a hand through the feet,
depending on how the contact with the con-
ductive surfaces is made. Sensory reactions to
contact current depend on the level of current,
the physical dimensions and anatomical fea-
tures of the exposed individual, the size of the
contact area (e.g., touch or grip), and unspeci-
ﬁed sensitivity factors unique to that individ-
ual (reviewed in Reilly 1998). For example,
adult men experience sensory thresholds at
electric currents between 100 and 500 µA,
with progressively lower thresholds for women
and children due to their smaller size; a child’s
lower perception threshold is about 50 µA.
Associations between residential magnetic
ﬁelds and the risk of childhood leukemia have
been observed, but the magnetic ﬁelds per se
appear to be too weak to cause biologic effects,
and leukemia bioassays in rodents are uni-
formly negative. It is conceivable that the
magnetic field measurements are acting as a
surrogate for some other exposure. An expo-
sure, such as contact currents, could be an
explanatory factor for the observed epidemio-
logic associations if three conditions are satis-
fied: a) an association is present between
contact current exposure and the measured
power-line magnetic field level, b) levels of
contact current expected in a home are sufﬁ-
cient to deliver an adequate dose to the bone
marrow, and c) a target population (i.e., small
children) has the opportunity to encounter
contact currents.
Association between magnetic fields and
contact voltages. In a computer model, two
sources of contact voltage were considered,
which appear either between the electrical
panel (P) and the water line entering the house
(W), or between the water line (W) and the
earth ground (E) (Kavet et al. 2000). The ﬁrst
source, VP–W, occurs in the grounding conduc-
tor that connects the neutral wire at the electri-
cal service panel (fuse or breaker box) to the
water line entering the house (as required by
the National Electrical Code). The grounding
conductor carries a fraction of a home’s net
load current producing an ohmic voltage across
the conductor’s length. Because appliance
frames also are connected via the third or
“green” wire in the power cord to the service
panel neutral, an individual can be exposed to
VP–W when simultaneously touching an appli-
ance frame and a water ﬁxture.
The second source arises from the voltage
between the water pipes and the earth, VW–E.
This voltage results from ground currents in the
primary and secondary electrical distribution
circuits that ﬂow from the water pipes into the
earth. VW–E also can result from induction
caused by magnetic ﬁelds from heavily loaded
power lines that may be nearby. VW–E produces
a voltage between water pipes and the drainpipe
(VW–D), because the drainpipe is sunk into the
soil and therefore becomes a component in the
earth return pathway. Exposure to a contact
voltage could occur to a person bathing while
contacting a water ﬁxture or the water stream.
If any segment of the water supply or drainpipe
is nonconductive, exposure does not occur.
Basic engineering principles suggest that, across
large populations, VW–E and the residential
magnetic ﬁeld should be associated with each
other (Kavet and Zaffanella 2002).
In a computer-modeled neighborhood,
Kavet et al. (2000) observed that VP–W is
highly correlated to the magnetic ﬁeld attrib-
utable to the ground current within a particu-
lar residence. In a pilot study of 36 residences
(Kavet and Zaffanella 2002), the degree of
correlation between contact voltages and mag-
netic field measurements varied. VP–W was
poorly correlated to spot-measured magnetic
ﬁelds (Bavg) (both log-transformed). This dis-
crepancy is due most likely to the effects of
magnetic ﬁelds from nearby lines, which may
have “swamped” the fields from the ground
path. On the other hand, VW–E was signifi-
cantly (p < 0.001) correlated to Bavg (both log-
transformed) with the highest levels of VW–E
(> 400 mV) associated with proximity to high
voltage transmission lines (i.e., probably due
to magnetic ﬁeld induction). VW–D, however,
was not signiﬁcantly correlated with Bavg (22
valid data points). The results suggest a posi-
tive association between magnetic ﬁeld expo-
sure and contact voltage due to VW–E, but a
more precise description of the relation
between VW–D and Bavg will require a larger
sample. VW–E is the source voltage for VW–D,
and VW–D is some fraction of VW–E, but the
fraction varies from house to house. Kaune
et al. (2002) failed to find an association
between ground currents and case versus con-
trol status for childhood cancer, but because
of large variations in the conductivity of water
pipes, ground currents may not correlate with
contact voltages.
Sufﬁcient dose to tissue. Biologic response
to an environmental exposure requires suffi-
cient dose as a necessary but not sole condition.
A key difﬁculty with attributing a causal inter-
pretation to the association between childhood
leukemia and magnetic ﬁelds has been the low
dose to target tissue associated with ambient
magnetic ﬁelds. For example, residential ﬁelds
away from appliances rarely exceed 1 µT, and
studies using anatomically representative com-
puter models report that a 5-µT 60-Hz mag-
netic field fails to induce even 1 mV/m (the
minimum “benchmark” dose for biologic
effects; NIEHS 1999) in an adult’s bone mar-
row, with lower values expected for children
because of their smaller size (Kavet et al. 2001).
Studies examining contact current dosime-
try report that the bone marrow of a child-
sized model’s lower arm experiences an average
of 5 mV/m per µA of contact current into the
hand, and 5% of the tissue achieves 13 mV/m
per µA (Dawson et al. 2001). Modeled adults
experience roughly 40% of the values of the
modeled child. Because exposure in the bath-
tub scenario (summarized above) can reach
30 µA or more, electric ﬁelds in a child’s mar-
row of up to 500 mV/m (0.5 V/m) are con-
ceivable, exceeding by several-fold the above
1 mV/m “benchmark dose.”
Opportunity for exposure. Although VP–W
can technically cause contact current to ﬂow,
it is most likely a minor source of exposure,
especially to children. Simultaneous contact
with an appliance and a water ﬁxture is prob-
ably not common and the reach may be
beyond a child’s physical dimensions. In addi-
tion, most appliance contact is with a dry
hand, which means the contact resistance can
exceed 100 K ohms, resulting in a relatively
low current. In contrast, contact with the
water ﬁxture in a bathtub involves a wet hand
that essentially short-circuits the insulating
outer layer of the skin. Moreover, if children
bathe several hundred times per year, then
ample opportunity exists for some level of
contact, although such behaviors have not
been studied.
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Table 6. Noise processes that compete with EMF interaction strength.
Noise process Symbol Source of competing chemical changes
Stochastic chemical noise N∆N Randomizing collisions and ﬂuctuations inherent to an
aqueous biological environment
Temperature variations N∆T Environmental and metabolic temperature ﬂuctuations
coupling to signiﬁcant biochemical temperature dependence
Concentration variations N∆C Physiological processes leading to variations in concentrations
of ions and molecules
Mechanical noise N∆M Motion of tissues leading to possible mechanical interference
with ongoing processes
Background electric ﬁelds N∆E Neuromuscular electrical activity and motion-created
streaming potentials that lead to background electric ﬁelds
Children’s Health | Brain et al.Summary of the contact–current metric.
Because the three conditions, association be-
tween exposures, sufﬁcient dose, and exposure
opportunity, have not been refuted in modeled
analyses, the contact-voltage explanation
remains viable. However, the key exposure
parameters have not yet been characterized in a
large-sample study. Furthermore, no bioassay
or in vitro model of childhood leukemogenesis
has been studied with controlled applications
of contact current, but molecular models of
childhood leukemia in molecular engineered
mice can provide insight on the possible role of
60-Hz bone marrow electrical ﬁelds. The use
of transgenic mice allows characterization of the
initial genetic alteration that can be applied to
the investigation of subsequent epigenetic fac-
tors such as 60-Hz currents through the bone
marrow. Thus, although some theoretical mod-
els support additional inquiry, the lack of de-
finitive data showing magnetic fields to be a
surrogate for exposure to contact voltages
adds uncertainty as to the direction of future
research.
Summary
In children, ALL represents approximately
75% of the total leukemia types. In acute
leukemia, initiating events tend to be genetic in
origin and commonly are represented by chro-
mosomal translocations. There are known and
suspected risk factors, and epidemiologic asso-
ciations between EMFs and childhood
leukemia have made EMFs a suspected risk
factor. Animal data on the effects of EMF
exposure, however, are overwhelmingly nega-
tive regarding EMF exposure per se being a sig-
niﬁcant risk for hematopoietic neoplasia. We
may fail to observe laboratory effects from
EMF exposure because typical power-line
EMFs do not give a “dose” detectable above
the many sources of “noise” in biologic sys-
tems. We may fail to detect EMF effects in
bioassay systems because EMFs themselves are
not the causal exposure in the epidemiologic
associations. “Contact voltages” have been pro-
posed as a novel exposure metric, and they
meet three plausibility conditions: association
with residential EMF levels, biologic effective
dose, and opportunities for exposure. If replica-
ble laboratory findings indicate that contact
voltages are important in leukemia risk, then
epidemiology studies might be designed to
explore this proposal further.
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